Does Peppermint Oil Gut Health Meta-Analysis work?

Updated October 2026

Quick Answer

Peppermint Oil Gut Health Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Results During treatment, all assessed abdominal symptoms showed significant (p Conclusion The study demonstrates patient-relevant improvement in gastrointestinal symptoms during treatment with Menthacarin while underlining its favorable tolerability profile.

Key Takeaways

  • 01Results During treatment, all assessed abdominal symptoms showed significant (p Conclusion The study demonstrates patient-relevant improvement in gastrointestinal symptoms during treatment with Menthacarin while underlining its favorable tolerability profile. [Linas I (2025)]
  • 02Introduction In disorders of gut-brain interaction including functional dyspepsia and irritable bowel syndrome, clinical focus has shifted from pathophysiological criteria to symptoms. [Linas I (2025)]
  • 03Methods A single-arm, low-intervention clinical trial into the effectiveness and tolerability of Menthacarin, a peppermint oil/caraway oil combination, was performed. [Linas I (2025)]
  • 04Taxonomic profiling at the phylum, family, and genus levels showed comparable relative abundances of dominant microbial taxa across all treatments, with no evidence of dysbiosis. [Angane M (2026)]
The current Migaku evidence database contains 2 reusable source documents for Peppermint Oil Gut Health Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - Results During treatment, all assessed abdominal symptoms showed significant (p Conclusion The study demonstrates patient-relevant improvement in gastrointestinal symptoms during treatment with Menthacarin while underlining its favorable tolerability profile. [Linas I (2025); evidence level 2] - Introduction In disorders of gut-brain interaction including functional dyspepsia and irritable bowel syndrome, clinical focus has shifted from pathophysiological criteria to symptoms. [Linas I (2025); evidence level 2] - Methods A single-arm, low-intervention clinical trial into the effectiveness and tolerability of Menthacarin, a peppermint oil/caraway oil combination, was performed. [Linas I (2025); evidence level 2] - Taxonomic profiling at the phylum, family, and genus levels showed comparable relative abundances of dominant microbial taxa across all treatments, with no evidence of dysbiosis. [Angane M (2026); evidence level 4] - The application of essential oils and plant extracts as natural food preservatives has gained increasing interest; however, their potential impacts on gut health and host physiology remain unknown. [Angane M (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.
  2. Synergistic Effects of Plant Essential Oils and Extracts on Gut Microbiota in Rats.